NAGE Stock Risk & Deep Value Analysis
Niagen Bioscience Inc
Healthcare • Biotechnology
DVR Score
out of 10
What You Need to Know About NAGE Stock
We analyzed Niagen Bioscience Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran NAGE through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.. Here's what we found.
How Risky Is NAGE Stock?
Overall Risk
Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.
Financial Risk
High - Cannot assess financials for a non-existent public entity.
Market Risk
High - Cannot assess market for a non-existent public entity.
Competitive Risk
High - Cannot assess competitive landscape for a non-existent public entity.
Execution Risk
High - Cannot assess execution for a non-existent public entity.
Regulatory Risk
High - Cannot assess regulatory environment for a non-existent public entity.
What Are the Red Flags for NAGE?
- âš
N/A - Company untraceable as publicly traded entity
Unlock NAGE Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Niagen Bioscience Inc (NAGE) Do?
Market Cap
$547.47M
Sector
Healthcare
Industry
Biotechnology
Employees
104
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Visit Niagen Bioscience Inc WebsiteIs NAGE Stock Undervalued?
Unlock the full AI analysis for NAGE
Get the complete DVR score, risk analysis, and more
Is NAGE Financially Healthy?
P/E Ratio
28.58
Does NAGE Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
N/A
Moat Sources
1 Identified
No moat can be assessed for a company that does not exist as a public entity.
Moat Erosion Risks
- •N/A - Cannot assess specific risks
NAGE Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive NAGE Stock Higher?
Near-Term (0-6 months)
- •N/A - Company untraceable as publicly traded entity
Medium-Term (6-18 months)
- •N/A - Company untraceable as publicly traded entity
Long-Term (18+ months)
- •N/A - Company untraceable as publicly traded entity
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for NAGE?
- ✓
Confirmation of NAGE's legitimate public listing and verifiable financial statements.
- ✓
Any verifiable news regarding an IPO or direct listing for 'Niagen Bioscience Inc'.
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for NAGE (Niagen Bioscience Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.


